The Advisory Group on Risk Evidence Education for Dementia: Multidisciplinary and Open to All.

ABSTRACT: The brain changes of Alzheimer's disease and other degenerative dementias begin long before cognitive dysfunction develops, and in people with subtle cognitive complaints, clinicians often struggle to predict who will develop dementia. The public increasingly sees benefits to accessing dementia risk evidence (DRE) such as biomarkers, predictive algorithms, and genetic information, particularly as this information moves from research to demonstrated usefulness in guiding diagnosis and clinical management. For example, the knowledge that one has high levels of amyloid in the brain may lead one to seek amyloid reducing medications, plan for disability, or engage in health promoting behaviors to fight cognitive decline. Researchers often hesitate to share DRE data, either because they are insu

SUBMITTER: Rosen AC 

PROVIDER: S-EPMC9901285 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature